Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Feb;47(2):109–112. doi: 10.1136/jcp.47.2.109

Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?

G Valente 1, R Orecchia 1, S Gandolfo 1, M Arnaudo 1, R Ragona 1, S Kerim 1, G Palestro 1
PMCID: PMC501821  PMID: 8132823

Abstract

AIMS--To determine whether immunohistochemical evaluation of the abatement of proliferating cells after a first course of radiotherapy could predict the final response to treatment in oral squamous cell carcinoma (SCC). METHODS--Frozen sections from 31 cases of histologically confirmed oral SCC were stained with the monoclonal antibody Ki67 at diagnosis and after 10 Gy of radiotherapy. The percentage difference of Ki67 positive cells among the biopsy specimens taken at the beginning and after 10 Gy was correlated with the clinical response obtained at the end of the treatment and its significance determined. RESULTS--The percentage of Ki67 positive cells at diagnosis had no significant correlation with the final therapeutic result of radiotherapy. By contrast, the 32% difference of proliferating cells after 10 Gy of radiotherapy significantly differentiated responders from non-responders (p < 0.05). Furthermore, the abatement of the growth fraction after 10 Gy of radiotherapy was significantly correlated with the complete response (p < 0.01). CONCLUSIONS--These data show that the immunohistochemical evaluation of the abatement of Ki67 positive cells after 10 Gy of radiotherapy provides an independent variable of responsiveness to radiotherapy, allowing a reliable prediction of the final therapeutic result to be made.

Full text

PDF
109

Images in this article

111Image
on p.111
111Image
on p.111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown D. C., Gatter K. C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology. 1990 Dec;17(6):489–503. doi: 10.1111/j.1365-2559.1990.tb00788.x. [DOI] [PubMed] [Google Scholar]
  2. Bush C., Price P., Norton J., Parkins C. S., Bailey M. J., Boyd J., Jones C. R., A'Hern R. P., Horwich A. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer. 1991 Aug;64(2):357–360. doi: 10.1038/bjc.1991.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Costa A., Salvatori P., Molinari R., Motta R., Cerutti A., Silvestrini R. Cell kinetics to monitor radioresponsivity in human epidermoid carcinoma. Basic Appl Histochem. 1986;30(2):209–213. [PubMed] [Google Scholar]
  4. Crocker J. Proliferation indices in malignant lymphomas. Clin Exp Immunol. 1989 Sep;77(3):299–308. [PMC free article] [PubMed] [Google Scholar]
  5. Deshmukh P., Ramsey L., Garewal H. S. Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling. Am J Clin Pathol. 1990 Aug;94(2):192–195. doi: 10.1093/ajcp/94.2.192. [DOI] [PubMed] [Google Scholar]
  6. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983 Jan 15;31(1):13–20. doi: 10.1002/ijc.2910310104. [DOI] [PubMed] [Google Scholar]
  7. Hall P. A., Richards M. A., Gregory W. M., d'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol. 1988 Mar;154(3):223–235. doi: 10.1002/path.1711540305. [DOI] [PubMed] [Google Scholar]
  8. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  9. Isola J., Kallioniemi O. P., Korte J. M., Wahlström T., Aine R., Helle M., Helin H. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol. 1990 Dec;162(4):295–301. doi: 10.1002/path.1711620404. [DOI] [PubMed] [Google Scholar]
  10. Kearsley J. H., Furlong K. L., Cooke R. A., Waters M. J. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer. 1990 Jun;61(6):821–827. doi: 10.1038/bjc.1990.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mothersill C., Seymour C. B., O'Brien A., Hennessy T. Proliferation of normal and malignant human epithelial cells post irradiation. Acta Oncol. 1991;30(7):851–858. doi: 10.3109/02841869109091834. [DOI] [PubMed] [Google Scholar]
  12. Nakano T., Oka K. Transition of Ki-67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study. Cancer. 1991 Aug 1;68(3):517–523. doi: 10.1002/1097-0142(19910801)68:3<517::aid-cncr2820680312>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  13. Peters L. J., Brock W. A., Chapman J. D., Wilson G., Fowler J. F. Response predictors in radiotherapy: a review of research into radiobiologically based assays. Br J Radiol Suppl. 1988;22:96–108. [PubMed] [Google Scholar]
  14. Sahin A. A., Ro J., Ro J. Y., Blick M. B., el-Naggar A. K., Ordonez N. G., Fritsche H. A., Smith T. L., Hortobagyi G. N., Ayala A. G. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer. 1991 Aug 1;68(3):549–557. doi: 10.1002/1097-0142(19910801)68:3<549::aid-cncr2820680318>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  15. Sinclair W. K. Cyclic x-ray responses in mammalian cells in vitro. Radiat Res. 1968 Mar;33(3):620–643. [PubMed] [Google Scholar]
  16. Swanson S. A., Brooks J. J. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Am J Pathol. 1990 Dec;137(6):1491–1500. [PMC free article] [PubMed] [Google Scholar]
  17. Vielh P., Chevillard S., Mosseri V., Donatini B., Magdelenat H. Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors. Am J Clin Pathol. 1990 Dec;94(6):681–686. doi: 10.1093/ajcp/94.6.681. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES